Novel developments in biomarkers for FTD

New biomarkers are needed that are sensitive to subtle changes, to improve diagnosis and disease monitoring in frontotemporal dementia (FTD). Martina Bocchetta, PhD, University College London, London, UK; Annakaisa Haapasalo, PhD, University of Eastern Finland, Joensuu, Finland; and Adolfo Garcia, PhD, University of San Andrés, Buenos Aires, Argentina, discuss the development of novel biomarkers for FTD.